MED
Undervalued by 126% based on the discounted cash flow analysis.
Market cap | $201.69 Million |
---|---|
Enterprise Value | $52.35 Million |
Dividend Yield | $6.6 (0%) |
Earnings per Share | $9.13 |
Beta | 1.16 |
Outstanding Shares | 10,937,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 6.88 |
---|---|
PEG | -5.42 |
Price to Sales | 0.26 |
Price to Book Ratio | 1.02 |
Enterprise Value to Revenue | 0.07 |
Enterprise Value to EBIT | 1.53 |
Enterprise Value to Net Income | 1 |
Total Debt to Enterprise | -0.79 |
Debt to Equity | -0.2 |
No data
No data
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and ...